NYSE · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Cadre Holdings, Inc. CDRE
6 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$610.3M
▲ 7.5% vs FY2024
Dividend streak
2 yrs
Raised every year since 2024
EPS · FY25
$1.02
Dividend / sh · FY25
$0.10
Payout · FY25
35%
ROE · FY25
14.0%
Net margin · FY25
7.2%
Dividend coverage
10.7×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 610.3M
Revenue, FY2025 · full 6-year series below
Revenue
Net income
7 cents of every revenue dollar became profit this year.
Per share
USD 1.02
Diluted EPS, FY2025
EPS
Dividend
Earnings covered the dividend 10.7 times — the rest stayed in the company.
Profitability
14.0%
Return on equity, FY2025
ROE
Operating margin11.0%
Net margin7.2%
Return on assets6.2%
Each USD of equity produced 14 cents of profit this year.
Returned to shareholders
USD 15.4M
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 15.4M
Net buybacks—
Share of profit35.0%
Consecutive raises2 years
USD 15.4M in dividends — 35% of the year's profit went back to shareholders.
Growth
+8.6% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+10.1%
+8.6%
Net income
+96.5%
+2.8%
EPS, diluted
+85.4%
−6.1%
Dividend / share
+5.9%
Returned to shareholders
+10.3%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.04B
Shares outstanding, FY2025
Change, 5 years+53.4%
Change, 10 years—
The share count grew 53% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 770.0M
total assets, end of FY2025
Total assetsUSD 770.0M
EquityUSD 317.8M
CashUSD 122.9M
Gross debtUSD 307.3M
Net debtUSD 184.4M
DepositsUSD 32.5M
Net debt stands at 58% of equity.
History
6 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
Revenue $B
0.6
0.6
0.5
0.5
0.4
0.4
Operating income $B
0.1
0.1
0.1
0.0
0.1
0.0
EBITDA $B
0.1
0.1
0.1
0.0
0.1
0.1
Income tax $B
0.0
0.0
0.0
0.0
0.0
−0.0
Net income $B
0.0
0.0
0.0
0.0
0.0
0.0
EPS, diluted $
1.02
0.90
1.02
0.16
0.44
1.40
Dividend / sh $
0.10
0.09
0.08
0.08
·
·
Payout %
35
39
31
198
101
·
ROE %
14.0
14.2
21.3
4.6
26.0
434.4
Shares out B
0.04
0.04
0.04
0.04
0.03
0.03
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
24 of 24
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed